High prevalence of toxinogenic Clostridium difficile in Nigerian adult HIV patients

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 11, 2011, Pages 667-669

  Onwueme, Kenolisa ^a,b   Fadairo, Yetunde ^c   Idoko, Lucy ^c   Onuh, James ^c   Alao, Olu ^d   Agaba, Patricia ^c   Lawson, Lovett ^d   Ukomadu, Chinweike ^a   Idoko, John ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Obala Foundation   (United States)

^c UNIVERSITY OF JOS   (Nigeria)

^d ZANKLI MEDICAL CENTRE   (Nigeria)

Author keywords

Clostridium difficile; Diarrhea; HIV; Nigeria; Sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; NIGERIA; OUTPATIENT; PILOT STUDY; PREVALENCE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLOSTRIDIUM DIFFICILE; DIARRHEA; FECES; FEMALE; HUMANS; MALE; NIGERIA; PILOT PROJECTS; PREVALENCE; RISK FACTORS; SENTINEL SURVEILLANCE;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 80054064697     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.07.014     Document Type: Article

References (10)

1. Bartlett J.G. Changing trends in bacterial infections: Staphylococcus aureus, bacterial pneumonia, Clostridium difficile. Top HIV Med 2007, 15:94-98.
2. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
3. Sosa A. Antibiotic policies in developing countries. Antibiotic policies: theory and practice 2005, 591-616. Kluwer Academic/Plenum, New York. I.M. Gould, J.W.M. van der Meer (Eds.).
4. Garcia C., Samalvides F., Vidal M., Gotuzzo E., Dupont H.L. Epidemiology of Clostridium difficile associated diarrhea in a Peruvian tertiary care hospital. Am J Trop Med Hyg 2007, 77:802-805.
5. Legaria M.C., Lumelsky G., Rosetti S. Clostridium difficile-associated diarrhea from a general hospital in Argentina. Anaerobe 2003, 9:113-116.
6. Nwokediuko S., Bababode B., Chinedu O.U., Ozoh G. Peculiarities of chronic diarrhea in Enugu, Southeastern Nigeria. J Health Sci 2002, 48:435-440.
7. Beadsworth MBJ, Perez AM, van Lieshout L, Watson A, Hart CA, Zijlstra E, et al. The prevalence of Clostridium difficile toxin as a cause of acute or chronic diarrhoea in a high HIV prevalence population in sub-Saharan Africa. European Society of Clinical Microbiology and Infectious Diseases. Minich, Germany: Blackwell Synergy; 2007.
8. Samie A., Obi C.L., Franasiak J., Archbald-Pannone L., Bessong P.O., Alcantara-Warren C., et al. PCR detection of Clostridium difficile triose phosphate isomerase (tpi), toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA, cdtB), and tcdC genes in Vhembe District, South Africa. Am J Trop Med Hyg 2008, 78:577-585.
9. Ticehurst J.R., Aird D.Z., Dam L.M., Borek A.P., Hargrove J.T., Carroll K.C. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006, 44:1145-1149.
10. Carroll KC. Tests for the diagnosis of Clostridium difficile infection: The next generation. Anaerobe Forthcoming, 2011 doi:10.1016/j.anaerobe.2011.01.002.